← FDA DRUG APPROVALS

FDA NDA · NDA016776

SORBITRATE

Sponsor: ASTRAZENECA

APPLICATION
NDA016776
TYPE
NDA
ORIGINAL APPROVAL
1970-12-07
LATEST ACTION
1999-01-26
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

SORBITRATEDiscontinued
ISOSORBIDE DINITRATE 10MG · TABLET, CHEWABLE · ORAL
SORBITRATEDiscontinued
ISOSORBIDE DINITRATE 5MG · TABLET, CHEWABLE · ORAL

Approval history

1999-01-26Labeling · Supplement 36 · standardAP
1996-10-11Manufacturing (CMC) · Supplement 35 · standardAP
1996-04-01Manufacturing (CMC) · Supplement 34 · standardAP
1982-01-21Manufacturing (CMC) · Supplement 23 · standardAP
1977-11-28Manufacturing (CMC) · Supplement 15 · standardAP
1970-12-07Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →